Detailed answers about LYMPHOGENIX LIMITED, including incorporation, status, business activity, and accounts information.
When was LYMPHOGENIX LIMITED founded?
LYMPHOGENIX LIMITED was officially incorporated on 7 May 2024 and is registered under company number 15704914. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is LYMPHOGENIX LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of LYMPHOGENIX LIMITED?
LYMPHOGENIX LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does LYMPHOGENIX LIMITED do?
LYMPHOGENIX LIMITED operates in the following sectors: 21100 - Manufacture of basic pharmaceutical products, 72190 - Other research and experimental development on natural sciences and engineering. These SIC codes provide insight into the company's business activities and industry focus.
What is LYMPHOGENIX LIMITED's registered address?
The registered office address of LYMPHOGENIX LIMITED is 71-75 SHELTON STREET, COVENT GARDEN, LONDON, UNITED KINGDOM, WC2H 9JQ. This is the official address filed with Companies House for legal and statutory correspondence.
Is LYMPHOGENIX LIMITED financially stable?
The most recent accounts for LYMPHOGENIX LIMITED were made up to 31 May 2025, filed as MICRO ENTITY. Next accounts are due by 28 February 2027.